Anzupgo Side Effects
Generic name: delgocitinib topical
Note: This document provides detailed information about Anzupgo.
Applies to delgocitinib topical: topical cream Side Effects associated with delgocitinib topical. Some dosage forms listed on this page may not apply specifically to the brand name Anzupgo.
Applies to delgocitinib topical: topical cream.
General adverse events
The most commonly reported adverse reactions reported in 1% of patients or less were application site pain, paresthesia, pruritus, erythema, bacterial skin infections (finger cellulitis), paronychia, other skin infections, leukopenia, and neutropenia.[Ref]
Dermatologic
- Frequency not reported: Non-melanoma skin cancers including basal cell carcinoma, eczema herpeticum, bacterial skin infections including finger cellulitis, paronychia, other skin infections
Hematologic
- Frequency not reported: Leukopenia, neutropenia
Local
- Common (1% to 10%): Application site reactions including application site pain, paresthesia, pruritus, erythema
Other
- Frequency not reported: Viral reactivation, including cases of herpes virus reactivation (herpes zoster)
See also:
References
1. (2025) "Product Information. Anzupgo (delgocitinib topical)." Leo Pharma Inc
More about Anzupgo (delgocitinib topical)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous topical agents
Patient resources
Professional resources
Related treatment guides
Further information
Anzupgo side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.